El Plan de acción regional sobre inmunización para las Américas (RIAP) constituye un paso fundamental para consolidar los avances alcanzados y proporciona una visión clara para enfrentar los desafíos actuales y futuros, con el objetivo de alcanzar las metas establecidas para el año 2030. Este ...plan es esencial para fortalecer los sistemas de salud, mejorar el acceso a la vacunación y optimizar la coordinación entre las partes interesadas, de manera de asegurar que todos los sectores de la población tengan la oportunidad de beneficiarse de programas de inmunización resilientes, eficaces y equitativos a lo largo del curso de vida. Diseñado en el marco de la política sobre Revitalizar la inmunización como un bien de salud pública para la salud universal y en consonancia con la Agenda de Inmunización 2030, en este plan se integran las prioridades definidas por los países y territorios, con indicadores que abordan seis líneas de acción: gobernanza, seguimiento, integración, comunicación, recursos humanos y toma de decisiones basada en la evidencia. Este enfoque integral e inclusivo reafirma el compromiso con el logro de la cobertura universal de salud y de los Objetivos de Desarrollo Sostenible. De cara al futuro, es esencial mantener un compromiso sólido a todos los niveles y adaptar las estrategias a los cambios que enfrentan los países y territorios, a fin de avanzar de manera eficaz en los esfuerzos de inmunización mediante mejores prácticas y enfoques innovadores. Se invita a todas las partes interesadas a unirse a este esfuerzo colectivo para garantizar la inmunización como un bien público y proteger a la población contra las enfermedades prevenibles por vacunación.
more
Le Plan d'action régional pour la vaccination dans les Amériques (RIAP) constitue une étape fondamentale pour consolider les progrès accomplis et offre une vision concrète pour relever les défis actuels et futurs en vue d'atteindre les objectifs fixés pour l'année 2030. Ce plan est essentiel... pour renforcer les systèmes de santé, améliorer l'accès à la vaccination et optimiser la coordination entre les parties prenantes, en veillant à ce que tous les secteurs de la population aient la possibilité de bénéficier de programmes de vaccination résilients, efficaces et équitables tout au long du parcours de vie. Conçu dans le cadre stratégique de la politique pour la Revitalisation de la vaccination en tant que bien de santé publique pour une santé universelle et aligné sur le Programme pour la vaccination à l’horizon 2030, le plan d’action synthétise les priorités déterminées par les pays et les territoires, en utilisant des indicateurs qui ciblent six axes stratégiques d’intervention : la gouvernance, la surveillance, l'intégration, la communication, les ressources humaines et la prise de décision fondée sur des données probantes. Cette approche globale et inclusive réaffirme la volonté de parvenir à la couverture sanitaire universelle et d'atteindre les objectifs de développement durable. À l'avenir, il sera essentiel de maintenir un engagement fort à tous les niveaux en adaptant les stratégies aux changements que connaîtront les pays et les territoires, afin de faire progresser efficacement leurs efforts de vaccination par la mise en œuvre de meilleures pratiques et d’approches novatrices. Toutes les parties prenantes sont encouragées à participer à cet effort collectif pour que la vaccination soit considérée comme un bien public et que la population soit protégée contre les maladies évitables par la vaccination.
more
This WHO laboratory manual provides the most up to date methods and procedures for the laboratory identification of yellow fever virus infection in humans. It provides guidance on the establishment and maintenance of an effective laboratory providing routine surveillance testing for yellow fever, wh...ich operates within the WHO coordinated Global Yellow Fever Laboratory Network (GYFLaN) capable of providing confirmation of yellow fever infection reliably and timely. This second edition supersedes the first edition of the 2004 WHO manual for the monitoring of yellow fever virus infection.
more
MEDBOX Issue Brief no.35: The first issue brief on the NTD Toolbox contains general strategies, roadmaps, key treatment guidelines, reports, and training material on Buruli ulcer, Chagas, and Leishmaniasis.
There has been a global outbreak of mpox since 2022; this outbreak has been caused by the strain of mpox virus called Clade 2 and has affected around 116 countries worldwide. The current surge in cases is being driven by the rapid spread of a different strain – Clade 1b – which is predominantly ...affecting countries across the African region, particularly DRC, Burundi, Kenya, Uganda and Rwanda [1]. The guidance in this document applies to both Clades of mpox. WHO publishes a dashboard of updated cases globally here. Different Clades and Sub-Clades of mpox behave slightly differently to each other; WHO is monitoring for any significant differences between the Clades, including transmission routes. This guidance will be updated as more information becomes available on this issue.
more
interim guidance, 25 November 2024
Disability inclusive shelter programming enables persons with disabilities to contribute more to their communities, participate more in consultations and decision-making, and facilitate their own protection. The key concepts include: Disability inclusive shelter programming is both a process and an ...outcome. By engaging persons with disabilities in the process, we will also improve the outcomes for persons with disabilities.
The disability community has the slogan “Nothing about us without us,” reminding that we should include and work with persons with disabilities and their representative groups rather than plan or make decisions on their behalf. Persons with disabilities should be engaged throughout shelter programme planning, implementation, monitoring and evaluation.
more
A GTFCC course on sample collection and testing with rapid diagnostic tests (or RDTs) for cholera, for healthcare workers.
Cervical cancer is a disease of the female reproductive tract caused primarily by oncogenic types of human papillomavirus
(HPV). In 2020, it was the fourth most common cancer among women worldwide, with an estimated 604 000 new cases and 342 000 deaths
This guide provides a systematic, practical approach to support primary care and other healthcare professionals to improve the care of peopel over the age of 18 years with difficult to manage asthma.
Bas Uele, Equateur, Haut Uele, Ituri, Kasai, Kasai Central, Kasai Oriental, Kinshasa, Kongo Central, Kwango, Kwilu, Lomami, Lualaba,
Maindombe, Maniema, Mongala, Nord-Ubangi, Nord-Kivu, Sankuru, Sud-Kivu, Sud-Ubangi, Tshopo et Tshuapa
We, the participants at the first-ever International Conference on PEN-Plus in Africa (ICPPA), held on 23– 25 April 2024 in Dar Es Salaam, United Republic of Tanzania, recognize the urgency of the rising burden of noncommunicable diseases (NCDs) across our Region. We are alarmed by the implication...s for social and economic development across Africa, considering that rising numbers of people under the age of 40 die unnecessarily.
more
Recognizing neglected tropical diseseases through changes on the skin.
App for Android and IOS, free of charge. The App is available in English and French, with plans to explore translations into other languages, such as Portuguese and Spanish, to better serve diverse communities.
A patient's skin... is the first and most visible structure of the body that a healthcare worker encounters during an examination. It is also highly visible to the patient, and any disease that affects it can be felt and has an impact on personal and social wellbeing. The skin is therefore an important entry point for diagnosis and management. Many human diseases are associated with changes in the skin, ranging from symptoms such as itching to changes in colour, feel and appearance.
more
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...nded eligibility for antiviral prophylaxis for pregnant women to prevent mother-to-child transmission of HBV; improving HBV diagnostics through use of point-of-care HBV DNA viral load and reflex approaches to HBV DNA testing; who to test and how to test for HDV infection; and approaches to promote delivery of high-quality HBV services, including strategies to promote adherence to long-term antiviral therapy and retention in care.
The 2024 guidelines include 11 updated chapters with new recommendations and also update existing chapters without new recommendations, such as those on treatment monitoring and surveillance for liver cancer.
more
L’objectif des lignes directrices 2024 est de fournir des recommandations actualisées et fondées sur
des données probantes sur les principaux sujets prioritaires. Ceux-ci concernent notamment les critères élargis et simplifiés de mise sous traitement pour les adultes, mais aussi désormais ...pour les adolescents, l’élargissement des critères d’éligibilité au traitement
antiviral prophylactique pour les femmes enceintes
afin de prévenir la transmission mère-enfant du VHB,
l’amélioration des tests de diagnostic de l’infection par le
VHB grâce à l’utilisation de tests de mesure de la charge
virale du VHB (ADN) sur le lieu de soins (“point-of-care
tests”) et d’approches réflexes pour la recherche de
l’ADN du VHB, et les critères pour déterminer à qui et
comment faire le test pour rechercher une infection par
le VHD.
more
